Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
RGNT · NYSE American · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Foreign private issuer
Regentis Biomaterials (RGNT) · oqro.io/stocks/RGNT · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
No open-market purchase by an insider of Regentis Biomaterials is on record in SEC filings since 2006.
No open-market sale by an insider of Regentis Biomaterials (RGNT) was filed with the SEC in the last 90 days.
No trade in Regentis Biomaterials (RGNT) was disclosed by a member of Congress in the last 12 months.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
$1.23−0.02 (−1.60%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
−83.6% (−$6.27) from Dec 4, 2025 to Nov 13, 2026 · adjusted daily closes
No disclosed open-market insider trades, politician trades or fund 13F changes in this period.
Adjusted close went from $7.50 on Dec 4, 2025 to $1.23 on Nov 13, 2026 (−83.6%). Disclosed in this range: 0 insider trades, 0 pre-arranged insider sales, 0 Congress trades.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Orthopedic, Prosthetic & Surgical Appliances & Supplies company based in Or Akiva. Foreign private issuer: reports on Form 20-F or 40-F.
Orthopedic, Prosthetic & Surgical Appliances & Supplies company based in Or Akiva. Foreign private issuer: reports on Form 20-F or 40-F. Its directors and officers file insider-trading forms (Form 4) only since 18 March 2026.
Last 12 months
Not enough history
Market value
–
Short interest: 6,660 shares sold short, −46.0% vs the previous count, 1.0 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.
Nothing reported yet
New filings show up here as soon as they are processed.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.